Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies

Journal of Neuroimmunology

Volumn 190, Issue 1-2, 2007, Pages 8-17

  Dati, G ^a   Quattrini, A ^c   Bernasconi, L ^b   Malaguti, M C ^c   Antonsson, B ^b   Nicoletti, F ^d   Alliod, C ^b   Di Marco, R ^d   Sagot, Y ^b   Vitte, P A ^b   Hiver, A ^b   Greco, B ^a   Roach, A ^b   Zaratin, P F ^a  

^a RBM Societa soggetta all'attivita di direzione e coordinamento da parte della Merck Serono SA T   (Italy)

^b MERCK SERONO S A   (Switzerland)

^c HSR   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Experimental autoimmune neuritis (EAN); Peripheral neuropathies; Recombinant human clusterin (r h CLU); Sciatic nerve crush

Indexed keywords

CLUSTERIN; RECOMBINANT CLUSTERIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; FEMALE; MOUSE; NERVE INJURY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROPHYLAXIS; REMYELINIZATION; SCIATIC NERVE;

ANIMALS; CLUSTERIN; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; MYELIN SHEATH; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURONS; ORGAN CULTURE TECHNIQUES; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; RECOMBINANT PROTEINS; SCIATIC NEUROPATHY; TREATMENT OUTCOME;

EID: 35448992437     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.014     Document Type: Article

References (30)

1. Calero M., Tokuda T., Rostagno A., Kumar A., Zlokovic B., Frangione B., and Ghiso J. Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem. J. 344 Pt 2 (1999) 375-383
2. Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B., and Ghiso J. Apolipoprotein j (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 50 4 (2000) 305-315
3. Constantinescu C.S., Hilliard B., Lavi E., Ventura E., Venkatesh V., and Rostami A. Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline. J. Neurol. Sci. 143 1-2 (1996) 14-18
4. de Jonge R.R., van Schaik I.N., Vreijling J.P., Troost D., and Baas F. Expression of complement components in the peripheral nervous system. Hum. Mol. Genet. 13 3 (2004) 295-302 (Feb 1)
5. de Silva H.V., Stuart W.D., Park Y.B., Mao S.J., Gil C.M., Wetterau J.R., Busch S.J., and Harmony J.A. Purification and characterization of apolipoprotein J. J. Biol. Chem. 265 24 (1990) 14292-14297
6. Di Marco R., Khademi M., Wallstrom E., Muhallab S., Nicoletti F., and Olsson T. Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10. J. Autoimmun. 13 2 (1999) 187-195
7. Gold R., Hartung H.P., and Toyka K.V. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 6 2 (2000) 88-91
8. Hirata K., Mitoma H., Ueno N., He J.W., and Kawabuchi M. Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J. Neurocytol. 28 8 (1999) 685-695 (Aug)
9. Hochgrebe T.T., Humphreys D., Wilson M.R., and Easterbrook-Smith S.B. A reexamination of the role of clusterin as a complement regulator. Exp. Cell Res. 249 1 (1999) 13-21
10. King R.H., Craggs R.I., Gross M.L., Tompkins C., and Thomas P.K. Suppression of experimental allergic neuritis by cyclosporin-A. Acta Neuropathol. (Berl) 59 4 (1983) 262-268
11. Jun Kimura. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and practice - Edition 3-2001 Part II Nerve conduction Studies, Chapter 4-5: 63-117.
12. Klimaschewski L., Obermuller N., and Witzgall R. Regulation of clusterin expression following spinal cord injury. Cell Tissue Res. 306 2 (2001) 209-216
13. Korn T., Toyka K., Harting H.P., and Jung S. Suppression of experimental autoimmune neuritis by leflunomide. Brain 124 Pt9 (2001) 1791-1802
14. McLaughlin L., Zhu G., Mistry M., Ley-Ebert C., Stuart W.D., Florio C.J., Groen P.A., Witt S.A., Kimball T.R., Witte D.P., Harmony J.A., and Aronow B.J. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106 9 (2000) 1105-1113
15. Poon S., Easterbrook-Smith S.B., Rybchyn M.S., Carver J.A., and Wilson M.R. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 39 51 (2000) 15953-15960
16. Poon S., Treweek T.M., Wilson M.R., Easterbrook-Smith S.B., and Carver J.A. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett. 513 2-3 (2002) 259-266
17. Previtali S.C., Archelos J.J., and Hartung H.P. Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome. Ann. Neurol. 44 4 (1998) 611-621
18. Quattrini A., Previtali S., Feltri M.L., Canal N., Nemni R., and Wrabetz L. Beta 4 integrin and other Schwann cell markers in axonal neuropathy. Glia 17 4 (1996) 294-306
19. Rosenberg M.E., Girton R., Finkel D., Chmielewski D., Barrie III A., Witte D.P., Zhu G., Bissler J.J., Harmony J.A., and Aronow B.J. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol. Cell. Biol. 22 6 (2002) 1893-1902
20. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 2 (1991) 173-182 (Apr)
21. Strocchi P., Rauzi F., and Cevolani D. Neuronal loss up-regulates clusterin mRNA in living neurons and glial cells in the rat brain. NeuroReport 10 8 (1999) 1789-1792
22. Tao R., and Aldskogius H. Glial cell responses, complement and apolipoprotein J expression following axon injury in the neonatal rat. J. Neurocytol. 28 7 (1999) 559-570
23. Tornqvist E., Liu L., Aldskogius H., Holst H.V., and Svensson M. Complement and clusterin in the injured nervous system. Neurobiol. Aging 17 5 (1996) 695-705
24. Torres-Munoz J.E., Redondo M., Czeisler C., Roberts B., Tacoronte N., and Petito C.K. Upregulation of glial clusterin in brains of patients with AIDs. Brain Res. 888 2 (2001) 297-301
25. Tschopp J., Chonn A., Hertig S., and French L.E. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J. Immunol. 151 4 (1993) 2159-2165
26. Vriesendorp F.J., Flynn R.E., Khan M., Pappolla M.A., and Brod S.A. Oral administration of type I interferon modulates the course of experimental allergic neuritis. Autoimmunity 24 3 (1996) 157-165
27. Wicher G.K., and Aldskogius H. Adult motor neurons show increased susceptibility to axotomy-induced death in mice lacking clusterin. Eur. J. Neurosci. 21 7 (2005) 2024-2028 (Apr)
28. Wilson M.R., and Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25 3 (2000) 95-98
29. Zhu J., Bai X.F., Hedlund G., Bjork J., Bakhiet M., Van Der Meide P.H., and Link H. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses. Clin. Exp. Immunol. 115 1 (1999) 56-63
30. Zou L.P., Ma D.H., Wei L., Van Der Meide P.H., Mix E., and Zhu J. IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue. J. Neurosci. Res. 56 2 (1999) 123-130